Am J Obstet Gynecol. 2015 Mar 26. pii: S0002-9378(15)00327-0. doi: 10.1016/j.ajog.2015.03.046. [Epub ahead of print]
SPECIAL SECTION—CANCER BIOMARKER UPDATE, PART I
Philip T. Cagle, MD; Randall J. Olsen, MD, PhD; Bryce P. Portier, MD, PhD; Hidehiro Takei, MD; David W. Bernard, MD, PhD
"Cancer biomarker testing is now a mainstay of 21st century pathology practice, embracing the pathologist’s role in patient selection for specific targeted therapies. Pathologists, oncologists, and others require direction in adapting to this new ever-evolving paradigm."